| __timestamp | Bristol-Myers Squibb Company | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 22223073 |
| Thursday, January 1, 2015 | 5920000000 | 6966842 |
| Friday, January 1, 2016 | 4940000000 | 9000499 |
| Sunday, January 1, 2017 | 6411000000 | 13741186 |
| Monday, January 1, 2018 | 6345000000 | 19040000 |
| Tuesday, January 1, 2019 | 6148000000 | 23559000 |
| Wednesday, January 1, 2020 | 11143000000 | 31931000 |
| Friday, January 1, 2021 | 10195000000 | 44981000 |
| Saturday, January 1, 2022 | 9509000000 | 54234000 |
| Sunday, January 1, 2023 | 9299000000 | 63806000 |
| Monday, January 1, 2024 | 11159000000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Bristol-Myers Squibb Company (BMY) and Viking Therapeutics, Inc. (VKTX) have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Bristol-Myers Squibb consistently allocated substantial resources to R&D, with expenditures peaking in 2020 at over 11 billion dollars. This represents a remarkable 145% increase from their 2014 spending. In contrast, Viking Therapeutics, a smaller player, showed a steady yet modest increase in R&D spending, growing from approximately 7 million dollars in 2015 to nearly 64 million dollars in 2023, marking an impressive 800% growth.
These figures highlight the diverse strategies of a pharmaceutical giant and an emerging biotech firm, each striving to make significant strides in medical innovation.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.
Viking Therapeutics, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Viking Therapeutics, Inc. vs Bausch Health Companies Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Novavax, Inc.
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?